Zeydin ACAR, Sinan ŞAHİN, Onur ŞEN, Murat ZİYREK

The Relationship between Proliferative Scars and Endothelial Function in Surgically Revascularized Patients

Background: Proliferative scars are benign fibrotic proliferationswhichdemonstrateabnormalwoundhealing in response to skin injuries. As postulated in the "response to injury hypothesis", atherosclerosis is also triggered by an endothelial injury. Keloid and ath-erosclerotic processes have many pathophysiological and cytological features in common.Aims: In this study, we investigated the relationship between proliferative scars and endothelial function in surgically revascularized patients. We aimed to test the hypothesis that atherosclerosis is a wound healing ab-normality.Study Design: Cross-sectional study.Methods: Consecutive patients who were admitted to the cardiology outpatient clinic with a history of coro-nary artery bypass grafting operation were evaluated. Thirty-three patients with proliferative scars at the me-dian sternotomy site formed the keloid group, and 36 age- and sex-matched patients with no proliferative scar at the median sternotomy site formed the control group. Endothelial function was evaluated by flow-mediated vasodilatation of the brachial artery via ul-trasonograhic examination.Results: There is no signicant difference according to the demographic data, biochemical parameters, clini-cal parameters and number of grafts between keloid and control groups. Endothelial-dependent vasodila-tory response was lower in the keloid group than the control group (9.30±3.5 and 18.68±8.2, respectively; p=0.001).Conclusion: This study showed that endothalial dys-function, which is strongly correlated with atheroscle-rosis, was more prominent in patients with prolifera-tive scars. As proliferative scars and atherosclerosis have many features in common, we might conclude that atherosclerosis is a wound healing abnormality

PDF

___

Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-26.
Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R, et al. Inflammation and carotid artery risk for ath- erosclerosis study (ICARAS). Circulation 2005;111:2203-9.
Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006;86:515-81.
Schroeder S, Kopp AF, Baumbach A, Meisner C, Kuettner A, Georg C, et al. Noninvasive detection and evaluation of athero- scleotic coronary plaques with multislice computed tomogra- phy. J Am Coll Cardiol 2001;37:1430-5.
Mathers CD, Loncar D. Projections of global mortality and bur- den of disease from 2002 to 2030. PLoS Med 2006;3:e442.
Caplan BA, Schwartz CJ. Increased endothelial cell turnover in areas of in vivo Evans blue uptake in the pig aorta. Atheroscle- rosis 1973;17:401-17.
Sprague EA, Steinbach BL, Nerem RM, Schwartz CJ. Influence of a laminar steady-state fluid-imposed wall shear stress on the bind- ing, internalization, and degradation of low-density lipoproteins by cultured arterial endothelium. Circulation 1987;76:648-56.
Ross R. The pathogenesis of atherosclerosis--an update. N Engl J Med 1986;314:488-500.
Park JH, Park TH, Chang CH. Earring embedded within earlobe keloids. Arch Plast Surg 2013;40:466-7.
Köse O, Waseem A. Keloids and Hypertrophic Scars: Are they two different sides of the same coin? Dermatol Surg 2008;34:336-46.
Liao WT, Yu HS, Arbiser JL, Hong CH, Govindarajan B, Chai CY, et al. Enhanced MCP-1 release by keloid CD14+ cells aug- ments fibroblast proliferation: role of MCP-1 and Akt pathway in keloids. Exp Dermatol 2010;19:142-50.
Ross, R. Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:419-20.
Vogel RA. Measurement of endothelial function by brachial artery flow-mediated vasodilation. Am J Cardiol 2001;88:31E- 34E.
Vinay K, Ramzi K, Stanley LR. Basic pathology 6th edition. W.B. Saunders company; 1997. p. 55-6.
Robles DT, Berg D. Abnormal wound healing: keloids. Clin Dermatol 2007;25:26-32.
Bian D, Zhang J, Wu X, Dou Y, Yang Y, Tan Q, et al. Asiatic acid isolated from centella asiatica inhibits TGF-?1-induced collagen expression in human keloid fibroblasts via PPAR-? activation. Int J Biol Sci 2013;9:1032-42.
Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210.
Wang R, Ghahary A, Shen Q, Scott PG, Roy K, Tredget EE. Hy- pertrophic scar tissues and fibroblasts produce more transform- ing growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 2000;8:128-37.
Dustan HP. Does keloid pathogenesis hold the key to under- standing black/white differences in hypertension severity? Hy- pertension 1995;26:858-62.
Ozdol C, Turhan S, Tulunay C, Altin AT, Atmaca Y, Candemir B, et al. Association between proliferative scars and in-stent re- stenosis. J Cutan Med Surg 2007;11:206-10.
Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wils- gaard T, Lochen ML, et al. Carotid atherosclerosis is a stron- ger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromso Study. Stroke 2007;38:2873-80.
Bhavsar S, Nimigan A, Hackam DG, Gorman DB, Gan BS, Spence JD. Keloid scarring, but not Dupuytren's contracture, is associated with unexplained carotid atherosclerosis. Clin Invest Med 2009;32:95-02.
Van der Meer IM, Del Sol IA, Hak AE, Bots ML, Hofman A, Witteman JCM. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam study. Stroke 2003;34:2374-9.
Kadar A, Glasz T. Development of atherosclerosis and plaque biology. Cardiovasc Surg 2001;9:109-21.
Van der Wal AC, Becker AE, M. van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary ath- erosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
Ross R, Glomset J, Harker L. Response to injury and atherogen- esis. Am J Pathol 1977;86:675-84.
Haust MD. Reaction patterns of intimal mesenchyme to injury, and repair in atherosclerosis. Adv Exp Med Biol 1974;43:35-57.
Vinay K, Ramzi K, Stanley L.R. Basic pathology 6th edition. W.B. Saunders company; 1997. p. 285-8.
Scott NA, Cipolla GD, Ross EC, Dunn B, Martin FH, Simonet L, et al. Identification of a potential role for the adventitia in vas- cular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996;93:2178-87.
Shi Y, O'Brien JE Jr, Mannion JD, Morrison RC, Chung W, Fard A, et al. Remodeling of autologous saphenous vein grafts: the role of perivascular myofibroblasts. Circulation 1997;95:2684- 93.
Lan TH, Huang XQ, Tan HM. Vascular fibrosis in atherosclero- sis. Cardiovasc Pathol 2013;22:401-7.
Dol-Gleizes F, Delesque-Touchard N, Marès AM, Nestor AL, Schaeffer P, Bono F. A new synthetic FGF receptor antago- nist inhibits arteriosclerosis in a mouse vein graft model and atherosclerosisin apolipoprotein E-deficient mice. PLoS One 2013;4:e80027.
Sánchez-Escuredo A, Pastor MC, Bayés B, Morales-Indiano C, Troya M, Dolade M, et al. Inflammation, metalloproteinases, and growth factors in the development of carotid atherosclerosis in renal transplant patients. Transplant Proc 2010;42:2905-7.
Manganaro A, Ciracì L, Andrè L, Trio O, Manganaro R, Sapori- to F, et al. Endothelial dysfunction in patients with coronary ar- tery disease: Insights from a flow-mediated dilation study. Clin Appl Thromb Hemost 2014;25.